P. Albert (Chester, United Kingdom), P. Chanez (Marseille, France)
LATE-BREAKING ABSTRACT: Inhibition of Pim1 kinase augments the anti-viral response to rhinovirus infection.
M. de Vries, N. Bedke, N. P. Smithers, P. H. Howarth, M. C. Nawijn, D. E. Davies (Groningen, Netherlands; Southampton, United Kingdom)
|  |
Correlation between red cell distribution width and disease severity and mortality in COPD patients
K. C. Tertemiz, A. Ozgen Alpaydin, C. Sevinc, H. Ellidokuz, C. Acara, A. H. Cimrin (Izmir, Turkey)
| |
The extended COPD care bundle and its impact on length of stay and readmission rate
E. Norman, C. Echevarria, A. Melville, R. Murray, N. Harker, D. Campbell, G. Afolabi, L. Robson, S. Bourke (North Shields, United Kingdom)
| |
Endoplasmic reticulum stress in bronchial tissue in patients with COPD and lung cancer
B. Nunez, S. Scrimini, A. Agustí, A. Iglesias, B. Cosio, M. Lopez, A. Rios, J. A. Torrecilla, J. Sauleda (Palma de Mallorca, Barcelona, Spain)
|  |
Analysis of the microbiota of sputum samples from patients with chronic obstructive pulmonary disease
N. Shen, J. Erb-Downward, Y. Du, J. Wang, G. Huffnagle, M. Gyetko, B. He (Beijing, China; Ann Arbor, United States Of America)
| |
Adrenomedullin optimizes mortality prediction in COPD
M. Brusse-Keizer, M. Zuur-Telgen, J. van der Palen, P. vanderValk, H. Kerstjens, W. Boerrsma, F. Blasi, K. Kostikas, B. Milenkovic, M. Tamm, D. Stolz (Enschede, Groningen, Alkmaar, Netherlands; Milan, Italy; Larissa, Greece; Belgrade, Republic Of Serbia; Basel, Switzerland)
| |
Characterising patterns of prescribing for UK COPD patients with comorbidities or history of pneumonia
D. Price, K. Bichel, D. West, V. L. Ashton, R. Stewart (Aberdeen, Cambridge, United Kingdom)
| |
COPD patients may suffer from frequent exacerbations but mostly do not - Subpopulations of a real life survey in more than 1.700 patients
D. Klopf, J. Rumpf, P. Maier-Stocker, C. Koehl, K. Thomas, H. P. Pfeuffer, P. Berg, C. Sommer (Nuernberg, Hof, Amberg, Munich, Lauf, Bad Neustadt, Erlangen, Garmisch-Partenkirchen, Germany)
| |
Are re-admissions with acute exacerbation of chronic obstructive pulmonary disease coded correctly?
M. Ahmed, B. Rickard, C. Lynch, G. Owen, S. Bradbury, K. Leech, M. Allen (Stoke-on-Trent, United Kingdom)
| |
Integrated care reduces hospital utilization among patients with severe COPD
E. Titova, S. Sunde, S. Steishamn, A. H. Henriksen (Trondheim, Norway)
| |
The value of the body composition analysis on COPD patients in different groups according to BMI
I. Marget, L. Bajcár, D. Magula, L. Cerná, E. Rozborilová (Nitra, Martin, Slovakia)
| |
The relationship between 24-hour symptoms and COPD exacerbations: Results from ASSESS
M. Miravitlles, H. Worth, J. J. Soler Cataluña, D. Price, F. De Benedetto, N. Roche, N. S. Godtfredsen, T. van der Molen, C. G. Löfdahl, L. Padullés, A. Ribera (Barcelona, Valencia, Spain; Fürth, Germany; Aberdeen, United Kingdom; Chieti, Italy; Paris, France; Copenhagen NV, Denmark; Groningen, Netherlands; Lund, Sweden)
| |
Endobronchial ultrasound in study of airway wall remodeling in COPD patients
J. Soja, P. Loboda, S. Mikrut, A. Cmiel, I. Gross-Sondej, L. Kasper, A. Andrychiewicz, K. Gorka, G. Pulka, K. Sladek (Cracow, Poland)
| |
The BODE index predicts mortality better than 2007 GOLD and GOLD ABCD
J. Bertó Botella, V. Pinto-Plata, M. Divo, J. M. Marín, B. Celli, C. Casanova, C. Cabrera, J. Zagaceta, P. Sánchez-Salcedo, E. López-Zalduendo, J. Zulueta, J. P. Juan Pablo, B. Celli (Pamplona, Spain; Boston, United States Of America)
| |
Pulse wave velocity in patients with COPD comorbid with arterial hypertension
T. Aksenova, V. Gorbunov, S. Tsarenok, L. Gagarkina (Chita, Russian Federation)
| |
Distribution and outcomes of the new Spanish phenotype-based guideline for COPD
B. G. Cosio, J. B. Soriano, M. Calle, J. J. Soler, J. P. De Torres, J. M. Marín, C. Martínez, P. De Lucas, I. Mir, G. Peces-Barba, N. Feu, I. Solanes, I. Alfageme, C. Casanova (Palma de Mallorca, Madrid, Valencia, Pamplona, Zaragoza, Oviedo, Córdoba, Barcelona, Sevilla, Santa Cruz de Tenerife, Spain)
| |
Pharmacological treatment of COPD in the on-sint cohort
L. Marín Barrera, C. López Ramírez, J. L. López-Campos, C. Calero Acuña, A. Fernández-Villar, C. Represas Represas, C. Ramos Hernández, R. Casamor (Sevilla, Madrid, Vigo, Barcelona, Spain)
| |